Citation Impact
Citing Papers
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
The changing epidemiology of lung cancer in Europe
2003
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy
1996
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study
1990 StandoutNobel
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
1995
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
1990 Standout
Cushing's syndrome
2015 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group.
1994
Mechanisms Underlying Postoperative Nausea and Vomiting and Neurotransmitter Receptor Antagonist-Based Pharmacotherapy
2007
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission
1999
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
1988
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Clinical applications of quinone-containing alkylating agents
2000
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Activity of gefitinib in advanced non-small-cell lung cancer with very poor performance status
2004
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma
2000
Lung cancer: current therapies and new targeted treatments
2016 Standout
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
1997
Factors Considered Important at the End of Life by Patients, Family, Physicians, and Other Care Providers
2000 Standout
A molecular signature of metastasis in primary solid tumors
2002 Standout
Users' Guides to the Medical Literature
2000 Standout
Methodological issues in antiemetic studies
1993
A single-blind study of the efficacy and safety of intravenous granisetron compared with alizapride plus dexamethasone in the prophylaxis and control of emesis in patients receiving 5-day cytostatic therapy
1992
Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience
1997
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens
1988
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
META-ANALYSES IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
1999
Cardiotoxicity of Chemotherapeutic Agents
2000
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
2016 Standout
A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung Cancer
1990
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
The health-related quality of life and survival of small-cell lung cancer patients: Results of a companion study to CALGB 9033
2002
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
2005 Standout
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Meta-analysis when only the median survival times are known: A comparison with individual patient data results
2005
Microtubules as a target for anticancer drugs
2004 Standout
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
2005 Standout
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
2000 Standout
Small-cell lung cancer
2005
Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma
1991
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: an Illinois Cancer Center study.
1994
Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group.
1989
Recent Advances in Radiation Oncology
1995
An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials
1998
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung Cancer
2000
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Cancer of the Ovary
2004 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Chemotherapy of brain metastases: Current status
1984
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
2003 Standout
Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood
2016
Chemotherapy of advanced non-small cell lung cancer
1999
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
1986
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide.
1984
Multimodality Therapy for Limited-Stage Small-Cell Lung Cancer
2016
Clinical management of dying patients.
1995
Chemotherapy versus chemotherapy plus irradiation in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up
1986
Systematic reviews of trials and other studies.
1998
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial
2000
Therapy of small cell lung cancer: a perspective on two decades of clinical research.
1988
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease
1985
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
2004 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Contribution of Dexamethasone to Control of Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Evidence
2000
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Cannabinoids for Medical Use
2015 Standout
Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer
1987
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
High-dose carboplatin in refractory ovarian cancer patients.
1987
Works of R Joss being referenced
Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer association of antitumor activity with initial tumor burden and treatment center
1990
?Fatigue and malaise? as a quality-of-life indicator in small-cell lung cancer patients
1993
Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC)
1988
Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study
1993
Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer
1992
Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine
1995
Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients
1994
Neuropharmacology of emesis and its relevance to anti-emetic therapy
1998
Phase II study of amsacrine in solid tumors: a report of the EORTC early clinical trial-group
1983
Acute Cerebrovascular Accident after Treatment with Cis-Platinum and Methylprednisolone
1983
A Phase I trial of Cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule
1984
The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: A prospective, randomized, double-blind trial
1986
Supportive therapy: Challenges for the '90s—Perspectives in antiemetic therapy
1993
Phase II trial of diaziquone (AZQ) in advanced malignant melanoma
1983
Role of radiation therapy in small cell anaplastic carcinoma of the lung.
1983
[Nausea and vomiting during chemotherapy of malignant tumors].
1981
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
1986
New drugs in small-cell lung cancer
1986
Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients.
1994
Whole-abdomen radiation in patients with advanced ovarian carcinoma after surgery, chemotherapy and second-look laparotomy
1984
New agents in non-small cell lung cancer
1984
A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer
1992
The symptomatic control of cytostatic drug-induced emesis. A recent history and review.
1990